glp 1 agonist history Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Historical timeline of GLP-1 biology,

Starting dose: 2.5 mg weekly (for 4 weeks) Titrated up in 2.5 mg increments every 4 weeks Common maintenance doses: 10 mg to 15 mg weekly Maximum studied dose: 15 mg weekly This slow escalation is designed to improve tolerance while still achieving substantial reductions in body weight and HbA1c

Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: Scandinavian cohort study

Federal regulators have approved the GLP-1 tablet Foundayo for use in weight management

A meta-analysis across randomized controlled trials found significant reductions in body weight averaging 12.4%, BMI by 4.0 kg/m2, and waist circumference by 8.0 cm

A Scandinavian cohort study by Engstrm et al